Chapter six Autologous bone marrow derived mesenchymal stromal cell treatment for refractory luminal Crohn’s disease: results of a phase I study
暂无分享,去创建一个
Koning | D. Hommes | W. Fibbe | J. Zwaginga | H. Fidder | M. Duijvestein | M. Wildenberg | H. Roelofs | A. Vos | Barbara B. Wendrich | H. Verspaget | E. Kooy-Winkelaar | A. Verhaar | Frits | G. R | V. Brink | Gijs r
[1] A. Cometa,et al. Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation , 2011, Bone Marrow Transplantation.
[2] P. Rutgeerts,et al. Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab† , 2010, Inflammatory bowel diseases.
[3] Manuel A. González,et al. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. , 2009, Gastroenterology.
[4] L. Dinesen,et al. P103 - Mesenchymal stem cells administered via novel selective mesenteric artery cannulation for the treatment of severe refractory Crohn's disease , 2009 .
[5] D. Büscher,et al. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis , 2009, Gut.
[6] M. Eijken,et al. Susceptibility of Human Mesenchymal Stem Cells to Tacrolimus, Mycophenolic Acid, and Rapamycin , 2008, Transplantation.
[7] D. Hommes,et al. Stem cells as potential novel therapeutic strategy for inflammatory bowel disease. , 2008, Journal of Crohn's & colitis.
[8] G. Dini,et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study , 2008, The Lancet.
[9] R. Zhao,et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell stem cell.
[10] Ross Tubo,et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.
[11] Franco Locatelli,et al. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. , 2007, Blood.
[12] M. Yarmush,et al. Mesenchymal Stem Cell-Derived Molecules Reverse Fulminant Hepatic Failure , 2007, PloS one.
[13] A. Braccini,et al. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. , 2007, Rheumatology.
[14] Ly Sun,et al. Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus , 2007, Lupus.
[15] L. Lagneaux,et al. Mesenchymal Stem Cells Derived from CD133‐Positive Cells in Mobilized Peripheral Blood and Cord Blood: Proliferation, Oct4 Expression, and Plasticity , 2005, Stem cells.
[16] O. Boyman,et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-α production , 2005, The Journal of experimental medicine.
[17] M. Pittenger,et al. Human mesenchymal stem cells modulate allogeneic immune cell responses. , 2005, Blood.
[18] Moustapha Hassan,et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells , 2004, The Lancet.
[19] F. Djouad,et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. , 2003, Blood.
[20] Elizabeth Simpson,et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. , 2003, Blood.
[21] Min Zhu,et al. Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.
[22] M. Andreeff,et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. , 2002, Cancer research.
[23] C. Carlo-Stella,et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.
[24] P. Conget,et al. Mesenchymal progenitor cells in human umbilical cord blood , 2000, British journal of haematology.
[25] S. Bruder,et al. Growth kinetics, self‐renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation , 1997, Journal of cellular biochemistry.
[26] D. García-Olmo,et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula including Crohn's disease. , 2008, Expert opinion on biological therapy.
[27] J. Soulier,et al. Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma , 2007, Leukemia.